dc.creator | Kohan Ivani, Karla | |
dc.creator | Gabler Neale, Fernando | |
dc.creator | Selman, | |
dc.creator | Vega Blanco, María Margarita | |
dc.creator | Romero Osses, Carmen | |
dc.date.accessioned | 2019-03-18T11:53:43Z | |
dc.date.available | 2019-03-18T11:53:43Z | |
dc.date.created | 2019-03-18T11:53:43Z | |
dc.date.issued | 2016 | |
dc.identifier | Journal of Cancer Research and Clinical Oncology, Volumen 142, Issue 1, 2018, Pages 47-58 | |
dc.identifier | 14321335 | |
dc.identifier | 01715216 | |
dc.identifier | 10.1007/s00432-015-1998-y | |
dc.identifier | https://repositorio.uchile.cl/handle/2250/166712 | |
dc.description.abstract | © 2015, The Author(s).Purpose: One of the hypotheses regarding the genesis of epithelial ovarian cancer involves the action of androgens on the proliferation of epithelial ovarian cells, as well as inclusion cysts. The purpose of the present study was to evaluate whether DHT causes changes in the TGF-β1 pathway that might modify the anti-proliferative effect of the latter. Methods: The levels of TGF-β1 protein, of its receptors (TGFBR1 and TGFBR2), of Smad2/3 (canonical signaling pathway protein) and of p21 (cell cycle protein) were assessed in ovarian tissues, epithelial ovarian cancer cell lines (A2780) and control cell lines (HOSE) through the use of immunohistochemistry and immunocytochemistry. Additionally, cell lines were treated with 100 nmol/L DHT, 10 ng/mL of TGF-β1 and DHT + TGF-β1 during 72 h in the presence and absence of a siRNA against androgen receptor. After treatment, TGFBR1 and TGFBR2 levels were detected through Western blotting and p21 was assessed through immunocyt | |
dc.language | en | |
dc.publisher | Springer Verlag | |
dc.rights | http://creativecommons.org/licenses/by-nc-nd/3.0/cl/ | |
dc.rights | Attribution-NonCommercial-NoDerivs 3.0 Chile | |
dc.source | Journal of Cancer Research and Clinical Oncology | |
dc.subject | Androgen receptor | |
dc.subject | Epithelial ovarian cancer | |
dc.subject | TGF-β signaling pathway | |
dc.title | Role of dihydrotestosterone (DHT) on TGF-β1 signaling pathway in epithelial ovarian cancer cells | |
dc.type | Artículos de revistas | |